| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 107 / 409 | 73rd | Q2 |
| Genetics (clinical) | 34 / 100 | 66th | Q2 |
| Pharmaceutical Science | 67 / 191 | 65th | Q2 |
| Genetics | 143 / 357 | 60th | Q2 |
| Molecular Medicine | 94 / 179 | 47th | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Cardiovascular Translational Research
Journal of Cardiovascular Translational Research is Scopus-indexed (Q2, CiteScore 5.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 1937-5387Verify ISSN ↗1937-5395Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$4,390 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Journal of Cardiovascular Translational Research indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q2, CiteScore 5.3.
What quartile is Journal of Cardiovascular Translational Research in Scopus?
Journal of Cardiovascular Translational Research is Q2 in Cardiology and Cardiovascular Medicine (rank 107 of 409), Q2 in Genetics (clinical) (rank 34 of 100) and Q2 in Pharmaceutical Science (rank 67 of 191), by CiteScore 2025. It is ranked in 5 subject areas in all.
What is the impact factor of Journal of Cardiovascular Translational Research?
Journal of Cardiovascular Translational Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.3, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.802, quartile Q1, with an H-index of 68.
How much does it cost to publish in Journal of Cardiovascular Translational Research?
The publisher lists an article processing charge of about US$4,390 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Journal of Cardiovascular Translational Research and what is its ISSN?
Journal of Cardiovascular Translational Research is published by Springer. Its print ISSN is 1937-5387 and its online ISSN is 1937-5395.
Is Journal of Cardiovascular Translational Research covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Journal of Cardiovascular Translational Research in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Journal of Cardiovascular Translational Research open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Journal of Cardiovascular Translational Research? — open metrics via OpenAlex
Journal of Cardiovascular Translational Research has an h-index of 78 and a 2-year mean of 2.42 citations per paper (OpenAlex). Its Scopus CiteScore is 5.3, quartile Q2. On 2-year citations it ranks #97 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Journal of Cardiovascular Translational Research published 135 papers in 2025; its busiest recent year was 2022 with 151. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Journal of Cardiovascular Translational Research? — latest 99 articles, 2026
In its latest 99 research articles (2026), authors are most often from China (50.8%), United States (8.2%) and India (6.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Journal of Cardiovascular Translational Research? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 1.1 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration50.8% of recent authorship from China
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.